AGOURA HILLS, Calif., June 12, 2013 /PRNewswire/ -- Biozoom (OTC QB: BIZM), creator of the world's first handheld, non-invasive spectroscopic device for measuring health and wellness biofeedback, announced the opening of a strategic sales and business development office in Agoura Hills, CA. The company selected southern California as the location for its first sales and business development office because of the region's combination of consumer and business to business opportunities, as well as its high profile globally. "California is a major center of commercial health and wellness activity, and its consumer population has a well-deserved reputation for being early adopters of products and services that promote healthy lifestyles," said Tefa Dexter, Biozoom's Director of Business Development.
California leads the organic food market in the US, with more than 2,700 certified organic farms and ranches. At the same time, Californians consume 36% of the organic foods produced in the United States. It is also home to a thriving complementary and alternative medicine community. One of only 16 states to licenses naturopathic doctors, California has more than 500 licensed practitioners, as well as hundreds of nutraceutical and pharmaceutical development companies, all dedicated to improving people's wellness.
"Agoura Hills is a perfect location for Biozoom," said Tefa Dexter. "We are just over the hill from the beautiful beaches of Malibu and close to Hollywood. This location gives us global exposure and puts us at the center of one of the most health and beauty conscious populations in the country. The entertainment industry has helped to create a beauty focused and anti-aging oriented consumer culture here. The Biozoom scanner's ability to help people — including celebrities — look and feel younger should propel the technology into the hands of businesses and consumers around the world," said Dexter.
The Biozoom scanner is a breakthrough in anywhere, anytime wellness management. It is the first practical way for consumers to measure their own biofeedback — including antioxidant levels — on demand. At the press of a button, the Biozoom scanner reflects a painless beam of light off skin and measures the wavelengths of key nutritional and fitness biomarkers to help improve wellness and physical performance. The results are delivered instantly to smartphones and the online portal.
In addition to developing relationships with California's health and wellness industry players, Dexter sees a major consumer market in the area's health-conscious mothers. "According to the United States Census Bureau there are over 2 million mothers in Los Angeles County alone. This is excellent for us because moms have adopted social networks and mobile devices in a big way. The Biozoom scanner, paired with the revolutionary mobile app, will give busy moms an easy way to track, record and motivate themselves and their families toward better wellness. A healthy mom makes for a healthy household," said Dexter.
Social media and mobile connectivity have attractions beyond the direct to consumer model. "We see the scanner's potential as a consumer loyalty tool being a major driver of the business to business market," said Dexter.
Biozoom is an innovative technology development company, specializing in the commercialization of our advances in mobile spectroscopy. Our intellectual property portfolio and ongoing research are positioned to apply Biozoom's technology breakthroughs to a wide range of markets. Our first consumer product, the Biozoom scanner, gives people the feedback they need to manage their health, wellness and fitness on demand. Tested in leading health institutions, our scanner is the first of its kind — a handheld, transdermal device for measuring biomarkers, including antioxidant levels, at the click of a button. Scan results — and customized wellness coaching based on those biomarkers — are sent instantly to a smartphone or online account. The scanner will enable leaders in the health and wellness industry to create new levels of customer loyalty and revenues as a result. For more information, visit www.biozoom.net.
This press release contains "forward-looking statements". Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, and specifically references to future potential purchase orders and re-orders from consumers and distributors. The reader can identify these forward-looking statements by forward-looking words such as "may," "will," "expect," "potential," "anticipate," "forecast," "believe," "estimate," "project," "plan," "continue" or similar words. The reader should read statements that contain these words carefully because they discuss future expectations, contain projections of future results of operations or of financial condition, or state other forward-looking information. Forward-looking statements include, but are not limited to, statements regarding potential products, customers, revenues, expansion efforts, and future plans and objectives of Biozoom, Inc. ("Biozoom"). The risk factors listed in our disclosure documents and the cautionary language therein provide examples of risks, uncertainties and events that may cause actual results to differ materially from the expectations and projections described by Biozoom in its forward-looking statements. Actual results relating to, among other things, product launch, sales, customer acceptance and market share could differ materially from those currently anticipated in such statements. Factors affecting forward-looking statements include: consumer preferences, competition from more established brands, ability to develop market share; changes in the operating costs; changes in economic conditions, foreign exchange and other financial markets; changes of the interest rates on borrowings; changes in the investments levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Biozoom operates; technological, mechanical and operational difficulties encountered in connection with Biozoom's development activities; and labor relation matters and costs. The reader should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Biozoom from time to time with the Securities and Exchange Commission and other regulatory authorities.